2 news items
Aptose Reports Results for the First Quarter 2024
APTO
14 May 24
, tuspetinib program costs included the healthy volunteer study, which was completed in 2023
Aptose Reports Results for the Fourth Quarter and Full Year 2023
APTO
26 Mar 24
costs for tuspetinib in 2023 represent the enrollment of patients in our APTIVATE clinical trial, our healthy volunteer trial, manufacturing
- Prev
- 1
- Next